60% PARKINSON’S PATIENTS IMPROVE AFTER REPAIR STEM CELL TREATMENT – PHYSICIANS CONFIRM RESULTS!
Majority of Parkinson’s Patients Improved After Stem Cell Treatment
February 04, 2010
“Two months after the stem cell therapy, I had a checkup for a hole in my eardrum that had been there for several years and it was healed up completely! As for the Parkinson’s symptoms, I am much stronger. I still fall occasionally but nothing compared to before therapy. People tell me that I am talking much better. I am blinking and smiling and I have more facial expression My ability to use utensils at mealtime is almost back to normal,” said Mr. Herman Engman, who was treated in January 2009.
More than 50% of the patients who improved reported decreased tremors while more than 60% experienced better speech. Approximately 60% of the patients surveyed had their improvement confirmed by their own physician.
“Now, I am walking like I was before I had Parkinson’s and my shaking is more under control I am sleeping longer at night and have also gained 10 pounds This is the first time in four years that I have been able to gain any weight,” stated Mr. John Andresen. Mr. Andresen was treated in July 2009.
Parkinson’s – Autologous Stem Cell Therapy Results (N=50)
Parkinson’s disease (also known as Parkinson disease or PD) is a degenerative disorder of the central nervous system that often impairs the sufferer’s motor skills, speech, and other functions.
Parkinson’s disease belongs to a group of conditions called movement disorders. It is characterized by muscle rigidity, tremor, a slowing of physical movement (bradykinesia) and a loss of physical movement (akinesia) in extreme cases. The primary symptoms are the results of decreased stimulation of the motor cortex by the basal ganglia, normally caused by the insufficient formation and action of dopamine, which is produced in the dopaminergic neurons of the brain. Secondary symptoms may include high level cognitive dysfunction and subtle language problems. PD is both chronic and progressive.
50 patients with Parkinson’s disease were treated with Autologous stem cells. Injection of the Stem Cells was performed by Lumbar Puncture. 200 ml of Bone Marrow was extracted out of the Iliaca crest and was concentrated for transplantation using gradient centrifugation. After treatment, the patients were evaluated using a post treatment survey. The results are presented below.
Nearly 60% of patients treated reported an improvement in their condition after treatment.
The average patient age was 65 years old. Patients as young as 38 years old and as old as 85 years old were treated. 80% were female. The average follow-up time was 7 months after treatment. Most patients experienced improvements after a couple of months.
Approximately 60% of improved patients reported better speech, handwriting and ability to use utensils. About 1/3 experienced improved ability to swallow and control saliva (drooling).
3 out of 4 patients who improved experienced decreased rigidity and a little more than half reported decreased tremors. Over 85% reported improved walking ability. While greater than 80% experienced improved gait.
60% of patients who reported improvements had them confirmed by their personal physician.
Approximately 40% of all improved patients reduced or eliminated their use of Parkinson’s medications.
In a Patient’s Own Words
Johannes W. – 72 years old
“…I no longer have any pain and I am completely drug free…”
Aubra P. – 59 years old
“…After the stem cell treatment I would no longer freeze…”
Ted E. – 66 years old
“…My neurologist saw me during this time and confirmed that I looked like I was doing very well…”
Jon A. – 71 years old
“…Now, I am walking like I was before I had Parkinson’s…”
Almost exactly a year ago, a study was published in The Open Stem Cell Journal, 2009, 1, 20-29 called Therapeutic Microinjection of Autologous Adult Human Neural Stem Cells and Differentiated Neurons for Parkinson’s Disease: Five-Year Post- Operative Outcome
The paper describes how a team consisting of members from
- 1UCLA School of Medicine and Brain Research Institute, UCLA, Los Angeles, California, USA;
- 2Movement Disorders Program, Los Angeles Neurosurgical Institute, Los Angeles, California, USA;
- 3Neural Transplantation and Molecular Biology Laboratories, NeuroGeneration, Inc, Los Angeles, California, USA and
- 4Feinberg School of Medicine, NorthwesternUniversity, Chicago, Illinois, USA
was able to isolate patient-derived (ADULT/REPAIR) neural stem cells, multiply them in vitro and ultimately differentiate them to produce mature neurons before they were reintroduced into the brain. The team was able to inject the adult stem cells without the need for immunosuppressants. Unlike embryonic stem cells, adult stem cell injections don’t cause a patient’s immune system to reject the cells.
The adult stem cells were highly beneficial for the patient involved in the study. “Of particular note are the striking results this study yielded — for the five years following the procedure the patient’s motor scales improved by over 80% for at least 36 months,” Levesque wrote.
IF YOU HAVE PARKINSON’S AND WANT TO KNOW IF YOU ARE A CANDIDATE FOR STEM CELL TREATMENT, http://bit.ly/PATIENTQUESTIONNAIRE